Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/24/2025

Treatment of Bipolar Disorder with Lamotrigine and Aripiprazole

Efficacy and Safety

  • The American Academy of Child and Adolescent Psychiatry recommends lamotrigine for maintenance therapy in adults with bipolar disorder, and aripiprazole for acute mania in adults 1
  • Aripiprazole is less likely to cause extrapyramidal symptoms compared to typical antipsychotics, though risk increases with long-term treatment, according to the Annals of Oncology 2
  • Risperidone carries increased risk of extrapyramidal symptoms when doses exceed 6 mg/24 hours, and may cause insomnia, agitation, anxiety, drowsiness, and orthostatic hypotension, as reported in the Annals of Oncology 2

Guideline Support and Clinical Considerations

  • The American Academy of Child and Adolescent Psychiatry suggests that medication choice should prioritize: (1) evidence of efficacy, (2) phase of illness, (3) side effect spectrum and safety, (4) patient's history of medication response 1
  • For agitated but cooperative patients, oral benzodiazepine + oral risperidone combinations are recommended specifically for acute agitation management, not maintenance treatment, according to the Annals of Emergency Medicine 3, 4, 5
  • Lamotrigine provides specific benefit for bipolar depression prevention, whereas risperidone lacks efficacy data for this indication, as stated in the Journal of the American Academy of Child and Adolescent Psychiatry 1